Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Investigational New Drugs|August 2, 2018
Sarcoid-like reaction mimicking disease progression in an ALK-positive lung cancer patient receiving lorlatinibFrancesco Facchinetti, Letizia Gnetti, Valeria Balestra, et al.
Pathologica|March 14, 2024
Testicular metastasis of prostate adenocarcinoma: the other side of orchiepididymitisGianluca Di Rienzo, Alessandro Tafuni, Umberto Maestroni, et al.
Technology in Cancer Research & Treatment|March 25, 2025
External Validation of the GRade, Age, Nodes and Tumor (GRANT) Score for Patients with Surgically Treated Papillary Renal Cell CarcinomaMichele Maffezzoli, Alessio Signori, Davide Campobasso, et al.
Bladder (San Francisco, Calif.)|February 13, 2025
Molecular classification using Lund University algorithm and clinical correlations in muscle-invasive bladder cancer: Insights from a retrospective studyDavide Campobasso, Simone Vezzini, Sebastiano Buti, et al.
Clinical Nuclear Medicine|August 10, 2021
18F-FDG and 68GA-Prostate-Specific Membrane Antigen PET/CT Perform Better Than CT Alone in Restaging Papillary Renal Cell Carcinoma RecurrenceDonatello Gasparro, Maura Scarlattei, Roberta Manuguerra, et al.
Molecular Therapy. Nucleic Acids|August 29, 2022
miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer modelsElisa Callegari, Paola Guerriero, Cristian Bassi, et al.
Critical Reviews in Oncology/Hematology|March 16, 2020
Role of innate and adaptive immunity in the efficacy of anti-HER2 monoclonal antibodies for HER2-positive breast cancerAntonino Musolino, Daniela Boggiani, Benedetta Pellegrino, et al.
Molecular Therapy. Nucleic Acids|November 16, 2022
Erratum: miR-199a-3p increases the anti-tumor activity of palbociclib in liver cancer modelsElisa Callegari, Paola Guerriero, Cristian Bassi, et al.
Pageof 10